Month: January 2023

Figure 1 Z-T Grade Shell Longitudinal SectionFigure 2 Z-T Drilling AreaFigure 3 Tahonitas Section Indicating Stepout Drill Results beyond 2020 Resource PitFigure 4 Los Reyes Project AreaVANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSX-V: PRYM, OTCQB: PRMNF, Frankfurt: 04V3) announces additional assay results from its recently completed Phase 2 drill program, and start of Phase 3 drilling. These results are from 48 drill holes in the Z-T area where Prime continues to delineate and expand the multi-million-ounce Los Reyes high-grade gold-silver deposit. Los Reyes and its three known gold-silver deposit areas (Guadalupe, Z-T and Central), has a mineralized footprint of over 15 square kilometres and is located in a highly prospective, 500-year old mining-friendly...

VANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) — Manganese X Energy (TSXV:MN) (OTCQB:MNXXF) (FSE:9SC) has wrapped up another successful year highlighted by the advancement of its wholly owned Battery Hill manganese project. The Battery Hill manganese project, which covers 1,228 hectares, is located approximately 5 km northwest of the town of Woodstock and is accessible via a new two-lane road. One of the highlights of 2022 was the positive results released in May in an independent Preliminary Economic Assessment, prepared by Wood Canada Ltd. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company along with video comments by Martin Kepman,...

VANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) — Nextech AR Solutions Corp. (OTCQX:NEXCF) (CSE:NTAR) (FSE:N29), a Metaverse Company and leading provider of augmented reality experience technologies and 3D model services, announced a patent update covering its artificial intelligence technology 3D model creation. The patent titled “Generating Three-Dimensional Models by Part” was filed in November. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company along with video comments from Nextech AR’s CEO, Evan Gappelberg. The video is available for viewing on “InvestmentPitch” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com...

SHENZHEN, China, Jan. 11, 2023 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today released its “2022 Customer Service Report” (“The Report”), a multi-dimensional report that summarizes the overall performance of Huize’s customer service and provides insights into insurance client profiles and the latest trends in China’s insurance industry. The Report reveals that in 2022, Huize provided professional insurance services to more than 780,000 families covering 2.04 million insurance policies. During the year, Huize provided claims assistance service to 70,000 customers, representing an increase of 62.8% year-over-year, with the total claim settlement amount increased by 8.8% year-over-year to...

REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the initiation of a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study will assess the pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® in healthy adult subjects. “We are delighted with the progress of the AVT05 development program,” said Joseph McClellan, Chief Scientific Officer. “As we enter our fifth biosimilar candidate into clinical studies, we reaffirm our commitment to improving patient lives by expanding access to affordable biologics.” In the twelve months up to October 2022, combined net revenues worldwide from sales of Simponi®...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the initiation of a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study will assess the pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi in healthy adult subjects. “We are delighted with the progress of the AVT05 development program,” said Joseph McClellan, Chief Scientific Officer. “As we enter our fifth biosimilar candidate into clinical studies, we reaffirm our commitment to improving patient lives by expanding access to affordable biologics.” In the twelve months up to October 2022, combined net revenues worldwide from sales of Simponi and Simponi Aria were over $2.2 billion, based on reported...

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18858 DKT 01/03/23 I 100 100 1.680 100 % 99,781198 18932 DKT 01/06/23 II 400 400 2.150 100 % 99,1767Total 500 500      The sale will settle 13 January 2023.

Harju County Court approved on 10 January 2023 the compromise agreement signed on 5 January 2023 by AS Baltika subsidiary Baltman OÜ and Kalaport OÜ, which ends the legal dispute between the two parties regarding the lease agreement for the Ivo Nikkolo store located at Suur-Karja 14 in Tallinn’s old town, which began in early 2021. The content of the dispute is described in more detail in the stock exchange announcement published by AS Baltika on 9 February 2021 and the information related to the compromise is disclosed in the 6 January 2023 stock exchange announcement. With the compromise, both Kalaport OÜ and Baltman OÜ mutually waived all claims and Baltman OÜ will continue to fulfill the lease agreement, taking into account the differences agreed in the compromise, from 01.02.2023. The parties have agreed that the terms of the compromise...

Xometry Europe Now Offers Localized Marketplaces In 9 Languages: English, German, French, Italian, Spanish, Polish, Dutch, Norwegian and Swedish The Xometry UK Marketplace Enables Fast Lead Times And Delivery For UK Customers The UK Customers Are Now Able to Quote and Purchase Parts Directly in Pound Sterling Xometry’s Proprietary Instant Quoting Engine Delivers Instant Pricing, Accurate Lead Times And Instant Feedback, Empowering The Creation Of Locally Resilient Supply ChainsMUNICH, Germany and LONDON, Jan. 11, 2023 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global online marketplace connecting enterprise buyers with suppliers of manufacturing services, today announced it continues to expand its footprint in Europe, with the launch of xometry.uk, a localized marketplace for UK customers. With the expansion into the...

Stock exchange release Lassila & Tikanoja plc 11 January 2023 at 10 a.m. Lassila & Tikanoja’s Shareholders’ Nomination Board submits proposals for the 2023 Annual General Meeting Lassila & Tikanoja’s Shareholders’ Nomination Board submits the following proposals to the Annual General Meeting to be held on 23 March 2023. The proposals will also be included in the notice of the 2023 Annual General Meeting. Members of the Board of Directors The Shareholders’ Nomination Board proposes the Board of Directors to have six (6) members. The Nomination Board proposes that Teemu Kangas-Kärki, Laura Lares, Sakari Lassila, Jukka Leinonen and Pasi Tolppanen are re-elected to the Board of Directors from among its current members and Anni Ronkainen is elected as a new member. In addition, the Nomination Board proposes that Jukka Leinonen...